Lynx Investment Advisory Dexcom Inc Transaction History
Lynx Investment Advisory
- $135 Billion
- Q2 2024
A detailed history of Lynx Investment Advisory transactions in Dexcom Inc stock. As of the latest transaction made, Lynx Investment Advisory holds 100 shares of DXCM stock, worth $7,048. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100Holding current value
$7,048% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding DXCM
# of Institutions
1,066Shares Held
361MCall Options Held
4.11MPut Options Held
3.61M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.28 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.43 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.15 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.08 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$842 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $27.2B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...